PA
ABBV icon

PFW Advisors’s AbbVie ABBV Stock Holding History

PFW Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$240K Buy
917
+47
+5% +$12K 0.07% 106
2026
Q2 		$219K Buy
+870
New +$187K 0.06% 117
2025
Q4 		– Sell
-983
Closed -$228K – 122
2025
Q3 		$228K Buy
+983
New +$200K 0.07% 119
2025
Q2 		– Sell
-1,221
Closed -$256K – 126
2025
Q1 		$256K Hold
1,221
– – 0.08% 104
2024
Q4 		$217K Buy
+1,221
New +$224K 0.07% 115
2024
Q2 		$206K Sell
1,200
-194
-14% -$32.1K 0.07% 114
2024
Q1 		$254K Buy
1,394
+39
+3% +$6.72K 0.08% 109
2023
Q4 		$210K Buy
+1,355
New +$198K 0.07% 114
2019
Q3 		$241K Buy
+1,219
New +$83.6K 0.07% 108

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

PFW Advisors's ABBV Position: Q3 2026 in Review

PFW Advisors increased its AbbVie (ABBV) stake by 5.4% in Q3 2026, buying an estimated $12K and bringing the position to 917 shares worth $240K. The position accounts for 0.07% of the portfolio, ranked #106.

PFW Advisors first reported a position in ABBV in Q3 2019 and has held it in 9 quarters since. The position peaked at $256K in Q1 2025. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • PFW Advisors held 917 shares of AbbVie worth $240K as of Q3 2026.
  • PFW Advisors bought 47 AbbVie shares in Q3 2026, an estimated $12K.
  • AbbVie made up 0.07% of PFW Advisors's portfolio in Q3 2026, its #106 holding.
  • PFW Advisors first reported a position in AbbVie in Q3 2019 and has held it in 9 quarters since.
  • PFW Advisors's AbbVie position peaked at $256K in Q1 2025.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on PFW Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.